Apeloa Pharmaceutical Co.,Ltd
000739
Rang in Aktien
#4401
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Aktienkurs
$3.07
Marktkapitalisierung
$3.56B
Veränderung (1 Tag)
-2.49%
Veränderung (1 Jahr)
36.03%
Land
CN
Handel Apeloa Pharmaceutical Co.,Ltd (000739)
Kategorie
Healthcare
EPS für Apeloa Pharmaceutical Co.,Ltd (000739)
EPS zum June 2026 TTM: $0.11
Laut den aktuellen Finanzberichten und dem Aktienkurs von Apeloa Pharmaceutical Co.,Ltd beträgt das aktuelle EPS des Unternehmens (TTM) $0.11. Am Ende des Jahres 2023 betrug das EPS $0.13 eine Steigerung gegenüber dem EPS von 2022, das $0.12 betrug.
EPS-Verlauf von Apeloa Pharmaceutical Co.,Ltd von 2000 bis 2026
EPS am Ende jedes Jahres
| Jahr | EPS | ändert |
|---|---|---|
| 2026 (TTM) | $0.11 | -9.42% |
| 2024 | $0.12 | -4.09% |
| 2023 | $0.13 | 3.17% |
| 2022 | $0.12 | -3.30% |
| 2021 | $0.13 | 20.64% |
| 2020 | $0.11 | 56.44% |
| 2019 | $0.07 | 47.70% |
| 2018 | $0.05 | 35.21% |
| 2017 | $0.03 | 2.11% |
| 2016 | $0.03 | 19.49% |
| 2015 | $0.03 | -42.77% |
| 2014 | $0.05 | 39.88% |
| 2013 | $0.03 | -22.94% |
| 2012 | $0.04 | 265.04% |
| 2011 | $0.01 | 136.54% |
| 2010 | $0.01 | -30.67% |
| 2009 | $0.01 | 17.19% |
| 2008 | $0.01 | -3.03% |
| 2007 | $0.01 | -45.00% |
| 2006 | $0.01 | 57.89% |
| 2005 | $0.01 | 24.59% |
| 2004 | $0.01 | 5.17% |
| 2003 | $0.01 | 7.41% |
| 2002 | $0.01 | -210.20% |
| 2001 | 0.00 | 716.67% |
| 2000 | 0.00 | 0.00% |
EPS für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | EPS | EPS-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 411.78% |
IN
|
